Our large-scale transcriptomics and confirmatory proteomic analyses in human post-mortem tissue have shown that SKP1A gene and protein are significantly reduced in the SNpc of PD patients, compared to age- and gender-matched controls without neurological disorders (Grunblatt et al. 2004). This evidence concerns the gene SKP1 and nervous system disorder.